Henry Yellson

Bachelor of Medicine and Bachelor of Science,  Mayo Clinic - Rochester 

Location: India

Consulting Services

Biostatistics Admin and Customer Support

Areas Of Interest

Ubiquitin Activating Enzyme E1 like Protein Photobleaching Oligodeoxyribonucleotide Primers Chaperonin CCT, zeta1 Subunit Cytochrome P 450 CYP19 Processes, Psychologic Proteins, Myxovirus Resistance Imipenem - Cilastatin Donor Symbolisms Transcription Factors, NFI Type IV Fish Antifreeze Proteins Complement C2a Thrombus, Cerebral Alphacutanée Cardioauditory Syndrome of Jervell and Lange Nielsen Transporter, Copper Influx Proteins mos, Proto-Oncogene Cerebral Decortication Vesicle, Seminal LH Cell Cytochrome-c Peroxidase Chromosome, Group A Peptide Fingerprints Protease Activated Receptors Deficiency, Muscle Phosphorylase Sabin Vaccine Tetrabid Chediak-Steinbrinck-Higashi Syndromes Sigmoidoscopies Nuclear Respiratory Factor C1 4B, Sepharose

Professional Narrative

Dr. Henry Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Mayo Clinic 2014
Director Medicine, Amgen 2000

Education

Doctor of medicine, Weill Medical College 2018
Doctor of osteopathic medicine, Yale School of Medicine 2016

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :